by Garth Sundem | Sep 18, 2018 | Featured, Latest News, Research
A little p63 goes a long way in embryonic development – and flaws in p63 can result in birth defects like cleft palette, fused fingers or even missing limbs. But once this early work is done, p63 goes silent, sitting quietly in the genome from that point forward....
by Garth Sundem | Aug 23, 2018 | Latest News, Research
If a new anti-cancer drug shows promise in a Petri dish, often the next step is to test the drug’s effect in mice. This system tends to work well with drugs that directly target cancer, but breaks down with immunotherapies. That’s because tumors from human cancer...
by Garth Sundem | Aug 14, 2018 | Latest News, Research
Patients with a greater than 10 pack/year history of smoking tend to develop an especially dangerous form of head and neck squamous cell cancer (HNSCC) for which prognosis remains poor and treatments have changed little during the past two decades. However, recent...
by Garth Sundem | Jun 6, 2018 | Latest News, Research
The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab. Often, the problem is that while treatments initially...
by Erika Matich | Jan 31, 2018 | Featured, Latest News, Patient Care, Research
Bob Rupp is a drummer. He works with the best musicians in the world and he’s celebrated for his contributions to the music scene in the Metro Area. There is even a day in his honor in the City and County of Denver. Rupp may not have believed he would live to see the...
